Relationship between vitamin D levels and pediatric celiac disease: a systematic review and meta-analysis
Background The relationship between Vitamin D levels and pediatric celiac disease (CD) remains controversial. In this study, we conducted a systematic review and meta-analysis to examine the relationship between Vitamin D and pediatric CD. Methods: We screened relevant studies from PubMed, EMBASE, and Web of Science published in English from January 1, 2000, to August 1, 2023. The included studies were assessed according to the STROBE checklist. Heterogeneity was quantified by Cochran’s Q test and the $ I^{2} $ statistic. Publication bias was estimated by Begg’s test and Egger’s test. Meta‐regression was used to detect potential sources of heterogeneity. Results: A total of 26 studies were included in the meta-analysis. Nineteen articles compared 25(OH)D3 levels between CD patients and control groups, average 25-hydroxyvitamin $ D_{3} $ [25(OH)$ D_{3} $ or calcidiol], and 1,25-dihydroxyvitamin $ D_{3} $ [1,25(OH)2$ D_{3} $ or calcitriol] levels, as the main forms of Vitamin D, there was a significant difference in CD patients and healthy controls (weighted mean difference (WMD) = − 5.77, 95% confidence interval (CI) = [− 10.86, − 0.69] nmol/L). Meanwhile, eleven articles reported the numbers of patients and controls with Vitamin D deficiency, there was a significant difference in the incidence of 25(OH)$ D_{3} $ deficiency between CD patients and healthy controls (odds ratio 2.20, 95% CI= [1.19, 4.08]). Nine articles reported changes in 25(OH)$ D_{3} $ levels before and after administering a GFD in patients with CD, the result of this study revealed the increase of 25(OH)$ D_{3} $ levels in CD patients after a gluten-free diet (GFD) (WMD = − 6.74, 95% CI = [− 9.78, − 3.70] nmol/L). Conclusions: Vitamin D levels in pediatric CD patients were lower than in healthy controls, and 25(OH)$ D_{3} $ deficiency was more prevalent in CD patients. We found that 25(OH)$ D_{3} $ levels were elevated in CD patients after GFD, which is consistent with previous research. Further well-designed, longitudinal, prospective cohort studies focusing on the role of Vitamin D in the pathogenesis of CD are therefore needed..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
BMC pediatrics - 24(2024), 1 vom: 16. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sun, Yanhong [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
25-hydroxyvitamin D |
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s12887-024-04688-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055171877 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055171877 | ||
| 003 | DE-627 | ||
| 005 | 20240316064740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240316s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12887-024-04688-0 |2 doi | |
| 035 | |a (DE-627)SPR055171877 | ||
| 035 | |a (SPR)s12887-024-04688-0-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Sun, Yanhong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Relationship between vitamin D levels and pediatric celiac disease: a systematic review and meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background The relationship between Vitamin D levels and pediatric celiac disease (CD) remains controversial. In this study, we conducted a systematic review and meta-analysis to examine the relationship between Vitamin D and pediatric CD. Methods: We screened relevant studies from PubMed, EMBASE, and Web of Science published in English from January 1, 2000, to August 1, 2023. The included studies were assessed according to the STROBE checklist. Heterogeneity was quantified by Cochran’s Q test and the $ I^{2} $ statistic. Publication bias was estimated by Begg’s test and Egger’s test. Meta‐regression was used to detect potential sources of heterogeneity. Results: A total of 26 studies were included in the meta-analysis. Nineteen articles compared 25(OH)D3 levels between CD patients and control groups, average 25-hydroxyvitamin $ D_{3} $ [25(OH)$ D_{3} $ or calcidiol], and 1,25-dihydroxyvitamin $ D_{3} $ [1,25(OH)2$ D_{3} $ or calcitriol] levels, as the main forms of Vitamin D, there was a significant difference in CD patients and healthy controls (weighted mean difference (WMD) = − 5.77, 95% confidence interval (CI) = [− 10.86, − 0.69] nmol/L). Meanwhile, eleven articles reported the numbers of patients and controls with Vitamin D deficiency, there was a significant difference in the incidence of 25(OH)$ D_{3} $ deficiency between CD patients and healthy controls (odds ratio 2.20, 95% CI= [1.19, 4.08]). Nine articles reported changes in 25(OH)$ D_{3} $ levels before and after administering a GFD in patients with CD, the result of this study revealed the increase of 25(OH)$ D_{3} $ levels in CD patients after a gluten-free diet (GFD) (WMD = − 6.74, 95% CI = [− 9.78, − 3.70] nmol/L). Conclusions: Vitamin D levels in pediatric CD patients were lower than in healthy controls, and 25(OH)$ D_{3} $ deficiency was more prevalent in CD patients. We found that 25(OH)$ D_{3} $ levels were elevated in CD patients after GFD, which is consistent with previous research. Further well-designed, longitudinal, prospective cohort studies focusing on the role of Vitamin D in the pathogenesis of CD are therefore needed. | ||
| 650 | 4 | |a 25-hydroxyvitamin D |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Meta-analysis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pediatric celiac disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Vitamin D |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Zhou, Qingxue |4 aut | |
| 700 | 1 | |a Tian, Dandan |4 aut | |
| 700 | 1 | |a Zhou, Jianming |4 aut | |
| 700 | 1 | |a Dong, Shilei |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC pediatrics |d BioMed Central, 2001 |g 24(2024), 1 vom: 16. März |w (DE-627)SPR027744639 |w (DE-600)2041342-7 |x 1471-2431 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g day:16 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12887-024-04688-0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.00 |q VZ |
| 951 | |a AR | ||
| 952 | |d 24 |j 2024 |e 1 |b 16 |c 03 | ||